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a b s t r a c t
Newcastle disease virus (NDV) belonging to the Paramyxovirinae subfamily is one of the most
devastating pathogens in poultry. Although vaccines are widely applied to control the infection,
outbreaks of Newcastle disease (ND) repeatedly happen. Currently, there are no alternative control
measures available for ND. In the present study, we found that sulfated Chuanmingshen violaceum
polysaccharide (sCVPS) were potent inhibitors of NDV in speciﬁc pathogen free chickens infected with a
virulent strain. With sCVPS treatment, the survival rate increased by almost 20% and virus titers in test
organs, including brain, lung, spleen and thymus, were signiﬁcantly decreased. The sCVPS also exhibited
the ability to prevent viral transmission by reducing the amount of virus shed in saliva and feces. Higher
concentrations of interferon α and γ in serum were detected in chickens treated with sCVPS, indicating
that one of the antiviral mechanisms may be attributed to the property of immunoenhancement.
Histopathological examination showed that sCVPS could alleviate the tissue lesions caused by NDV
infection. These results suggest that sCVPS are expected to be a new alternative control measure for NDV
infection and further studies could be carried out to evaluate the antiviral activity of sCVPS against other
paramyxoviruses.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Paramyxoviruses within the Paramyxoviridae family are envel-
oped, negative-sense single-stranded RNA viruses, which comprise
many important human and animal pathogens, including Measles
virus, Mumps virus, Newcastle disease virus (NDV), Parainﬂuenza
viruses, respiratory Syncytial virus, and Hendra and Nipah viruses
(Aguilar and Lee, 2011; Bhella et al., 2002; Bousse et al., 2004). These
pathogens cause many well-known diseases, including rubeola,
parotitis and some of the deadliest zoonoses, leading to a signiﬁcant
number of deaths every year (Aguilar and Lee, 2011). Newcastle
disease (ND), caused by infections of virulent NDV, is regarded as the
fourth-most important animal disease in terms of the lost number of
livestock and can cause enormous economic loss due to its highly
contagious, worldwide distribution and high ﬂock mortality
(Kapczynski et al., 2013; Miller et al., 2010). There is no antiviral
drug available for ND and so far the only recommended prevention
method is vaccination (Elizondo-Gonzalez et al., 2012). However,
there are signiﬁcant differences between the current vaccine strains
and prevailing NDV strains, which induce continual outbreaks of ND
even in vaccinated poultry ﬂocks (Zhang et al., 2011). Thus, it is
urgent to ﬁnd new alternative control measures.
Sulfated polysaccharides have sulfate groups esteriﬁed with the
polysaccharide hydroxyl groups and exhibit multiple bioactivit-
ies such as antiviral, anticancer, antioxidative, anticoagulant and
immune-strengthening effects (Jiménez-Escrig et al., 2011; Jiao
et al., 2011; Nguyen et al., 2012; Wijesekara et al., 2011; Moura
Neto et al., 2014). It has been over 50 years since the ﬁrst report on
the antiviral activity of sulfated polysaccharides (Gerber et al.,
1958). Varieties of sulfated polysaccharides that possess a wide
spectrum of antiviral properties have been separated from differ-
ent plants or synthesized (Pujol et al., 2007; Witvrouw and De
Clercq, 1997; Chrestani et al., 2009; Chen et al., 2014; Ghosh et al.,
2009). Moreover, some of them exhibit the potential ability to
inhibit the infection of Paramyxoviruses (Song et al., 2013c). The
mechanism of action can be ascribed to the interaction of sulfated
polysaccharides with viral envelope glycoproteins leading to pre-
vention of virus entry (Damonte et al., 2004; Harden et al., 2009;
Pujol et al., 2007).
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As it has been demonstrated that some sulfated polysacchar-
ides exhibit potent antiviral activity, it would be expected that
there are more candidates with antiviral properties by sulfated
modiﬁcation of polysaccharides. Therefore, we previously have
studied polysaccharides extracted from Chuanmingshen violaceum
(CVPS), and found that sulfated Chuanmingshen violaceum poly-
saccharides (sCVPS) possessed remarkable inhibitory effect of duck
enteritis virus (Song et al., 2013b) and NDV (Song et al., 2013c),
while non-sulfated polysaccharides did not show any activity.
Since the promising antiviral activity of sCVPS that was detected
in vitro, this study was conducted to evaluate whether sCVPS
could show antiviral activity in speciﬁc pathogen free (SPF)
chickens infected with a virulent NDV strain in order to develop
a new alternative control measure for NDV infection.
Results
Survival rate
The survival rate of chickens in each group is shown in Fig. 1.
There were no deaths in each group at 2 days post-infection (dpi),
but after 3 dpi the chickens began to die. The survival rates of
chickens treated with sCVPS were higher than those in the untreated
group and the CVPS-treated group at 3 dpi and 4 dpi. The high dose
of sCVPS-treated (sCVPS-H) group exhibited the highest survival rate,
decreasing from 92.59% at 3 dpi to 33.33% at 4 dpi, while the survival
rate of the untreated group fell from 74.07% at 3 dpi to 16.67% at
4 dpi. In the CVPS-treated group, the survival rate was a little higher
than that in the untreated group at 3 dpi, but it declined to the same
value (16.67%) at 4 dpi. In addition, the chickens in the medium dose
of sCVPS-treated (sCVPS-M) group had a higher survival rate than
low dose of sCVPS-treated (sCVPS-L) group. At 5 dpi, no chickens
were alive except in sCVPS-H group and sCVPS-M group. The survival
rates were approximately 20% and 10%, respectively.
Virus titers
To test whether sCVPS and CVPS could reduce virus amount in
chickens, several tissues, including lung, spleen, thymus and brain
were collected and the virus titers of these tissues were determined
by measuring the TCID50 values (Fig. 2). The virus replicated more
rapidly in lung, spleen and thymus when compared with the brain
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Fig. 1. The survival rate of chickens in each group. The number of alive chickens in
each group was recorded at 2, 3, 4 and 5 dpi, respectively. The survival rate of each
group was then calculated according to the formula: survival rate¼the number of
alive chickens/the total number of chickens. At 5 dpi, the signiﬁcant difference
(Po0.05) was observed between the sCVPS-H group and the untreated group
according to the results of the Chi-square test.
Fig. 2. Virus titers of test organs in each group. The lung, spleen, thymus and brain were collected at 2, 3 and 4 dpi. After homogenate, the supernatant was used to
determine the virus titer on chicken embryo ﬁbroblasts. The dotted line in the brain at 2 dpi showed the detection limit. The virus titers of these brain samples which was
lower than detection limit was inoculated into embryonated eggs for virus positive test. A cycle symbol indicated a brain sample was virus positive. “n” represents the
signiﬁcant differences (Po0.05) observed between the untreated group and the treated groups.
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tissue. Moreover, in these three organs, the virus titers reached the
maximum values at 3 dpi and then declined. The virus titer in the
brain continually increased over the experimental period. After
sCVPS-treatment, the virus titers were reduced signiﬁcantly in the
test organs; the CVPS control treatment did not show the same
potent effects on inhibiting virus proliferation. The virus titers from
chickens treated with the high and medium doses of sCVPS were
lower than those in sCVPS-L group. The spleen and thymus of the
sCVPS-treatment group exhibited a signiﬁcant decrease in the virus
titers (Po0.05) at 2 and 3 dpi, but no signiﬁcant differences were
observed at 4 dpi. However, the virus titers of lung and brain did
not decline signiﬁcantly at 2 dpi, but signiﬁcant decreases (Po0.05)
were observed at 3 and 4 dpi.
Virus shedding
The virus-shedding assay was designed to evaluate the role of
sCVPS and CVPS in reducing the transmissibility in NDV-infected
chickens. Therefore, oropharyngeal and cloacal swabs were col-
lected from sCVPS and CVPS treated and untreated chickens at 2,
3 and 4 dpi, the virus titers were then determined by measuring
the TCID50 values (Fig. 3). The amount of virus shed in orophar-
yngeal and cloacal swabs was reduced when treated with sCVPS.
After treatment with sCVPS-H and sCVPS-M, the amount of virus
shed in oropharyngeal swabs at 3 dpi as well as in cloacal swabs at
4 dpi were signiﬁcantly reduced (Po0.05). Moreover, in the
sCVPS-H-treated group, the amount of virus from oropharyngeal
swabs at 4 dpi as well as in cloacal swabs at 3 dpi was signiﬁcantly
decreased (Po0.05). However, CVPS and sCVPS-L exhibited little
effect in inhibiting virus shedding.
The changes of serum cytokines
It is widely reported that polysaccharides possess the ability to
enhance the body's immunity, thus the concentrations of serum
cytokine possessing antiviral property, including IFN-α and IFN-γ
were determined by ELISA. As shown in Fig. 4, the concentrations
of IFN-α and IFN-γ were increased after NDV infection when
compared with uninfected group. The concentrations of IFN-α and
IFN-γ of NDV-infected chickens treated with sCVPS were higher
than those in untreated chickens. Chickens treated with a medium
dose of sCVPS exhibited signiﬁcantly improved production of IFN-
α (throughout the experiment) and IFN-γ (until 4 dpi) when
compared with the uninfected group (Po0.05). The production
of IFN-α and IFN-γ in sCVPS-L group was also signiﬁcantly
augmented when compared with uninfected group (Po0.05). In
addition, the IFN-α concentration of chickens treated with the
medium dose of sCVPS was signiﬁcantly higher than that in the
untreated group at 3 dpi (Po0.05); the IFN-γ concentrations in
sCVPS-M group at 2 dpi as well as sCVPS-L group at 4 dpi were
also higher than in the untreated group (Po0.05).
Histopathology study
NDV infections always cause severe lesions in various organs.
Consequently, a histopathology assay was conducted to assess the
pathological changes and whether treatment with sCVPS could
alleviate the lesions. As shown in Fig. 5, virus infection induced
serious necrosis in the spleen (Fig. 5B); with sCVPS treatment, the
main histopathological changes were hyperemia and focal necrosis
(Fig. 5C). In the thymus, nearly complete necrosis of the cortex was
observed in the untreated group (Fig. 5E); little necrosis and
congestion were detected in sCVPS-treated group (Fig. 5F). In the
Fig. 3. Virus titers of oral and cloacal swabs collected from each group on 2, 3 and
4 dpi. The virus titers were determined on chicken embryo ﬁbroblasts. “n”
represents the signiﬁcant differences (Po0.05) observed between the untreated
group and the treated groups.
Fig. 4. The concentrations of interferon-α and γ in serum obtained from each group
at 2, 3 and 4 dpi. The interferon concentrations were determined by ELISA. “n”
represents the signiﬁcant differences (Po0.05) observed between the normal
group and the NDV-infected groups. “§”represents the signiﬁcant differences
(Po0.05) observed between the untreated group and the treated groups.
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brain, capillary hyperemia was found in the untreated group
(Fig. 5H); with sCVPS treatment, the lesions became milder
(Fig. 5I). These observations were also proved by the lesional score
(Table 1). When compared with the untreated group, the signiﬁ-
cantly lower lesional scores on spleen, thymus, brain, lung and
kidney were observed in the sCVPS-treated groups except CVPS-L
group (Po0.05). No signiﬁcant differences were observed in
lesional scores on liver and heart between the sCVPS-treated and
untreated groups. CVPS did not show any activity to inhibit the
histologic lesions caused by NDV infection.
Discussion
It has been over 50 years since live and inactivated vaccines
made by lentogenic strains, including LaSota, B1 and F were used
Fig. 5. The histopathological changes of the CVPS-H, untreated and normal groups. In spleen (A–C, 200), NDV infection induced serious necrosis (B, denoted by
arrowhead); with sCVPS treatment, the main histopathological changes were hyperemia and focal necrosis (C, denoted by arrowhead); A, normal group. In thymus (D–F,
200), serious necrosis induced by NDV was observed (E, denoted by arrowhead); little necrosis and congestion were detected in sCVPS-treated group (F, denoted by
arrowhead); D, normal group. In brain (G–I, 200), the lesions were illustrated by hyperemia (H, denoted by arrowhead); sCVPS could alleviate the lesion (I, denoted by
arrowhead); G, normal group.
Table 1
Lesional scores for each group on 4 dpin
Group Spleen Thymus Brain Liver Lung Heart Kidney
CVPS-H 3.5670.51c 5.4470.51b 0.4470.20b 1.3370.34a 3.2270.39c 2.0070.58a 2.2270.19c
CVPS-M 4.4570.39c 7.3370.58a 0.5670.20b 1.2270.39a 4.0070.67bc 1.7870.51a 3.1170.70bc
CVPS-L 6.0071.00b 7.6771.15a 1.1170.19a 1.5670.20a 4.7870.51ab 1.4470.20a 4.5670.84a
CVPS 6.6770.58a 8.0071.00a 1.0070.33a 2.0070.33a 5.1170.77ab 1.5670.53a 4.2270.77ab
Untreatment 7.6770.58a 8.6770.58a 1.4470.19a 1.8970.51a 5.0070.33a 1.6770.34a 4.8970.38a
a,b,cSigniﬁcant differences exist when there are not the same letters on each column (Po0.05).
n Lesional scores of each organ were obtained by multiplying the degree of severity (0¼no lesions, 1¼mild lesions, 2¼moderate lesions, and 3¼severe lesions) with the
extent of lesions (1¼ low extent, 2¼ intermediate extent, and 3¼ large extent).
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for NDV control (Han et al., 2008; Miller et al., 2009a). These
vaccine strains belonging to genotypes (I and II) are divergent from
the current circulating strains (mainly genotypes VI and VII) in
their biology, serology and genetics, so poultry cannot achieve the
desirable immunity, leading to outbreaks occurring year after year
(Dortmans et al., 2012; Alexander, 2001; Rui et al., 2010). The
chemotherapeutic drug ribavirin showed potent inhibitory effects
against many paramyxoviruses, but it exhibited very poor antiviral
activity against NDV (Elizondo-Gonzalez et al., 2012). In the past
few years, there has been much research focused on developing an
alternative control measure from sulfated polysaccharides, but
results only showed in vitro activity (Wang et al., 2010; Zhao et al.,
2010; Nguyen et al., 2012; Elizondo-Gonzalez et al., 2012). In the
present study, we ﬁrst evaluated the anti-NDV potency of sulfated
polysaccharides in vivo and found that sCVPS was capable of
protecting chickens from NDV infection and improving the survi-
val rate by almost 20% in a dose-dependent manner, but non-
sulfated CVPS exhibited no anti-NDV activity (Fig. 1). These results
suggested higher amounts of sCVPS for treatment. Infection with
virulent NDV always causes rapid death in susceptible poultry,
nearly 100% mortality within 3–6 dpi (Wakamatsu et al., 2006). In
our study we observed the same result, with no chickens surviving
at 5 dpi in the untreated group (Fig. 1). This study also provided
in vivo evidence for the theory that sulfated modiﬁcation could
improve the antiviral activity of polysaccharides.
NDV starts its replication at the site of infection and is then
transported to other organs through blood, except for lentogenic
strains (Liu et al., 2012; Kapczynski et al., 2013). Virus titers are
expected to be an indicator of viral proliferation and an index for
assessing the inhibitory effect of sCVPS. This study found that sCVPS-
treatment could reduce the viral load in the test organs (Fig. 2), and
virus titers in the spleen and thymus were signiﬁcantly decreased
earlier than those in the lung and brain. The results suggest that the
immune organs may act as the target site for sCVPS in vivo. In
addition, our results are consistent with the observations that the
viral reproduction reached peak at 3 dpi in organs except for the
brain (Dortmans et al., 2011).
In NDV-infected birds, large amounts of viruses are excreted into
the environment through secretions including ﬁne aerosols, large
droplets and feces. The spread of NDV may then take place by
inhalation or ingestion of these secretions (Saif et al., 2008). Thus,
there is an opportunity to minimize the impact of an outbreak and
inhibit the transmission of disease if a reduction in virus shedding is
achieved (Miller et al., 2009b). However, recent studies have
revealed that classic vaccines showed lower ability to reduce viral
shedding than the vaccines formulated with the homologous
genotype of currently circulating viruses which is not commercially
available (Miller et al., 2007; 2009b; 2013). Our results have
demonstrated that sCVPS could signiﬁcantly decrease the amount
of virus shed in saliva and feces (Fig. 3). This property may enable
sCVPS to be used for the control of NDV transmission. In addition,
we also found that infection with virulent NDV could induce viral
shedding that starts at 2 dpi, which consists with previous ﬁndings
(Miller et al., 2007, 2009b, 2013). There were other studies showing
that the onset of viral shedding was at 3 dpi in chickens and pigeons,
indicating that these differences may be due to varying replication
efﬁciencies (Guo et al., 2014).
The immune system plays a key role in protecting the body
against foreign pathogens through many ways including innate
immunity and acquired immunity. The cell-mediated immunity
induced by infection of virulent NDV is probably negligible due to
the rapid death of birds, so the innate immune response is the
primary contributor to the inhibition of virus growth and spread
(Kapczynski et al., 2013; Miller et al., 2013). Type I and II interferon
(IFN α and γ) are in the front line in inhibiting virus infections, thus
up-regulation of these cytokines is critical for antiviral immunity
(Mibayashi et al., 2007; Shrestha et al., 2006). In this study,
treatment with the medium dose of sCVPS resulted in a signiﬁcant
increase of IFN α and γ concentration, but the high dose group
appeared to be the same level with the untreated group (Fig. 4).
These results suggest that the medium dose of sCVPS exhibited its
inhibitory effect by immunoenhancement while the antiviral activity
of high dose of sCVPS was achieved by another pathway such as
directly inactivating viruses.
According to the pathogenicity, NDV strains are usually divided
into three pathotypes: lentogenic, mesogenic and velogenic strains
(Snoeck et al., 2009). The velogenic viruses are further classiﬁed into
vicerotropic and neurotropic strains based on different clinical signs
(Snoeck et al., 2009). The main histopathological characteristic
related to infection of vicerotropic strain is serious necrosis in
lymphoid tissues, especially in the spleen and gut-associated lym-
phoid tissue (Cattoli et al., 2011). In contrast, the neurotropic strain
predominately induces lesions of central nervous system, which
consist of hypertrophy/hyperplasia of vascular endothelium, moder-
ate gliosis, and multifocal necrosis of the Purkinje cells (Cattoli et al.,
2011). Thus spleen, thymus and brain were selected as the target
organs to evaluate the tissue lesions. This study also scored histolo-
gical lesions for each organ, which allowed us to evaluate the
changes of the lesions by quantitative data. Our results showed that
mild lesions were observed in the chickens treated with the high
dose of sCVPS, which suggested that sCVPS could slow down the
histopathological changes (Fig. 5 and Table 1). In addition, severe
necrosis in spleen (Fig. 5B) and thymus (Fig. 5E) was observed; only
mild cerebral lesions were observed (Fig. 5H). These results sug-
gested that F48E9 strain belongs to vicerotropic pathotype.
In conclusion, sCVPS possess the ability to inhibit NDV infection
in chickens by promoting survival rate, reducing virus titer and
viral shedding, enhancing immune response and alleviating tissue
lesions. With the promising in vivo anti-NDV properties reported
in this study, sCVPS exhibits potential for NDV control, and further
studies should be conducted for evaluating the antiviral activity
against other paramyxoviruses.
Materials and methods
Preparation of sCVPS and CVPS
CVPS was separated by decoction as previously described (Song
et al., 2013a). The content of polysaccharides was 93.85%. It was
sulfated by the chlorosulfonic acid-pyridine method to yield sCVPS
with 0.95 degree of sulfation (Song et al., 2013b). CVPS and sCVPS
were dissolved in sterile physiological saline, respectively, and then
the solutions were sterilized by the circulating steam method.
Virus
Newcastle disease virus (F48E9 strain) was provided by the
Department of Prevention Veterinary Medicine, Sichuan Agricul-
tural University (Ya'an, China). Viruses were propagated in 10-day-
old SPF chicken embryo eggs and the 50% egg infectious dose
(EID50) was measured as 10–8.17/mL.
SPF chickens and experimental design
SPF fertile eggs were bought from the Beijing Laboratory Animal
Centre, Beijing, China and hatched by an automatic incubator. All
chickens were reared in separate biosafety level 2 isolators under
uniform conditions with sufﬁcient feed and water. The experimental
protocol was approved by the National Institute of Animal Health
Animal Care and Use Committee at Sichuan Agricultural University
(approval number 2010-010)
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At 14 days old, 180 chickens were randomly divided into six
groups and challenged with 0.1 mL NDV suspension at a dose of
2104 EID50 through nasal drip and eye-drop, except the blank
control group. Then, chickens in sCVPS-H, sCVPS-M and sCVPS-L
groups were administered with 0.1 mL sCVPS at concentrations of 8,
4 and 2 mg/kg body weight, respectively; in CVPS-treated groups
with 0.1 mL of CVPS (4 mg/kg body weight); in the untreated group
and blank control group with an equal volume of physiological
saline. The sCVPS, CVPS and physiological saline were given through
intramuscular injection, once a day for 4 successive days.
Tissue virus titers assay
Three chickens from each group were sacriﬁced at 2, 3 and
4 dpi, and brain, lung, spleen and thymus were collected. These
organs were homogenized in Phosphate Buffer Solution (PBS),
followed by centrifugation at 10,000 g for 20 min. The virus titers
were then determined on chicken embryo ﬁbroblasts as follows.
Serial 10-fold dilutions of supernatant of tissue homogenates were
prepared with cell culture media and subsequently added into
cells in 96-well plates. After incubation for 2 h at 37 1C, the
inoculums were aspirated and cells were washed three times with
PBS. Then, culture media were added and cells were re-incubated
for 72 h at 37 1C. Finally, cytopathic effects of cells in each well
were observed and virus titers were calculated by the Reed–
Muench method (Reed and Muench, 1938). The mean virus titers
were presented as ( log10TCID50/g tissue) (Dortmans et al., 2011).
Virus shedding assay
The virus shedding assay was performed as previously described
(Miller et al., 2007). Oral and cloacal swabs were collected from
three chickens per group at 2, 3 and 4 dpi and put into tubes
containing 1 mL PBS supplemented with penicillin (2000 units/mL),
gentamicin (200 μg/mL) and amphotericin B (4 μg/mL). After twice
freezing and thawing and fully shaking, the tubes were centrifuged
at 10,000 g for 10 min. Then, the virus titers of the supernatant were
measured as in the method reported above.
Serum cytokines assay
Blood samples (three chickens per group) from jugular vein were
put into sterile tubes followed by clotting at 37 1C for 30 min. Then,
the serum was separated by centrifugation. The concentrations of
cytokines including IFN-α and IFN-γ in serum were determined by
using the ELISA kit according to the manufacturer's instructions
(Bio-Swamp Immunoassay R&D Center, Shanghai). Brieﬂy, serial 2-
fold dilutions of standard cytokine were prepared with standard
diluent, and then 50 μL of each dilution was added into the
antibody-coated microtiter plate. The 40 μL of each serum sample
together with 10 μL biotinylated antibody were added. The plate
sealed by a closure membrane was allowed to incubate at 37 1C for
30 min, followed by washing ﬁve times with wash buffer. HRP-
conjugate reagent was then added into each well and the plate was
incubated at 37 1C for 30 min. After washing, 50 μL chromogen
solution A and B were added and the plate was incubated at 37 1C
for 15 min. Finally, 50 μL stop solution was added and the optical
density at 450 nm was measured by a microplate reader (Bio-Rad,
USA). The sample concentration was calculated according to the
constructed standard curve.
Histopathological assay
The chickens from the treated and untreated groups were
sacriﬁced at 4 dpi. A small piece of the tissues, including brain,
spleen, thymus, heart, liver, lung and kidney were excised and
ﬁxed in PBS containing 10% formalin. The samples were then
washed with water overnight followed by dehydration with a
graded ethanol solution series and xylene. After embedding in
parafﬁn, a 5 μm section of each tissue was procured and stained
with hematoxylin – eosin for histopathological evaluation under
an optical microscope. Three slides from different part of each
tissue (3 chickens per group) were analyzed. The whole lesions for
each tissue were scored by multiplying the degree of severity
(0¼no lesions, 1¼mild lesions, 2¼moderate lesions, and 3¼severe
lesions) with the extent of lesions (1¼ low extent, 2¼ intermediate
extent, and 3¼ large extent) (Gerez et al., 2014). For each organ, the
maximal lesional score was 9 and the minimal score was 0.
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